Paxlovid Cuts Risk Of Long Covid Study Finds
Posted to the preprint server medRxiv on Saturday, the research — which included more than 56,000 veterans with a positive coronavirus test — found that more than 9,000 patients given Paxlovid (a combination of the medications nirmatrelvir and ritonavir) within the first five days of their infection had a 26 percent lower risk of developing 10 of 12 different long COVID conditions. These lingering effects include heart disease, blood disorders, fatigue, liver disease, kidney disease, muscle pain, neurocognitive impairment (such as difficult thinking or “brain fog”), and shortness of breath....